Projects funded by the NCN
A double whammy for the NF-κB signalling pathway: development of TAK1 and IKKβ degraders against inflammation-driven diseases
2022/47/I/NZ7/03324
Keywords:
PROTACs targeted protein degraders TAK1 kinase IKKβ kinase NF-κB nuclear factor inflammation cancer
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński, Collegium Medicum
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 12
Call: OPUS 24 (LAP) - announced on 2022-07-15
Amount awarded: 2 061 296 PLN
Project start date (Y-m-d): 2024-01-09
Project end date (Y-m-d): 2028-01-08
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.